›› 2010, Vol. 9 ›› Issue (2): 90-93.

• 临床研究 • 上一篇    下一篇

含糖透析液对糖尿病透析患者透析低血糖和低血压的影响

周凡力1 邹贵勉2 车文体2 王 俊1 蒋玉红2 廖 琪   

  1. 广西桂林市人民医院肾内科,解放军第181医院肾内科
  • 收稿日期:2009-04-14 修回日期:1900-01-01 出版日期:2010-02-12 发布日期:2010-02-12
  • 通讯作者: 邹贵勉

Influence of glucose-added dialysate on intradialytic hypoglycemia and hypotension in hemodialysis patients with diabetic nephropathy

ZHOU Fan-li1, ZOU Gui-mian2, Che Wen-ti2, WANG Jun1, JIANG Yu-hong2, LIAO Qi   

  1. 1Department of Nephrology, People’s Hospital of Guilin City, Guilin 541002, China; 2Department of Nephrology, No. 181 Hospital of PLA, Guilin 541002, China
  • Received:2009-04-14 Revised:1900-01-01 Online:2010-02-12 Published:2010-02-12

摘要:

【摘要】目的 探讨含糖透析液对糖尿病透析患者发生透析低血糖和低血压的影响,及其代谢指标的变化。方法 对17例维持透析的糖尿病患者进行自身对照试验,前2月使用无糖透析液,后2月换成含糖5.5 mmol/L的透析液,比较前后患者透析低血糖和低血压的发生率,以及代谢指标的变化。 结果 使用无糖透析液时,患者发生透析低血糖和低血压分别为7.6%和18.3%;使用含糖透析液后,患者发生透析低血糖和低血压明显下降,分别为1%和10.7%,P<0.01和P<0.05。而糖化血红蛋白和血脂等代谢指标则无明显变化,P>0.05。结论 在糖尿病肾病的透析患者使用含糖透析液,有利于防止透析低血糖和低血压,而对患者代谢无明显影响。

关键词: 透析液, 透析低血糖, 透析低血压, 糖尿病肾病

Abstract:

【Abstract】 Objective To explore the influence of glucose-added dialysate on incidences of intradialytic hypoglycemia and hypotension and on metabolic parameters in hemodialysis patients with diabetic nephropathy. Methods Self-control study was conducted in 17 patients with diabetic nephropathy on hemodialysis. The patients were dialyzed with glucose-free dialysate for a period of 2 months, and then were changed to glucose-added dialysate for another period of 2 months. The incidences of intradialytic hypoglycemia and hypotension and the changes of metabolic parameters were compared between the two periods. Results The incidences of intradialytic hypoglycemia and hypotension were 7.6% and 18.3%, respectively, after the period using glucose-free dialysate; the incidences decreased to 1% (P<0.01) and 10.7% (P<0.05), respectively, after the period using glucose-added dialysate. Metabolic parameters including glycosylated hemoglobin and blood lipid profiles remained unchanged (P>0.05). Conclusion Hemodialysis with glucose-added dialysate is beneficial to maintain normal blood glucose and blood pressure in patients with diabetic nephropathy during hemodialysis, but their metabolic parameters remain unchanged.

Key words: Intradialytic hypoglycemia, Intradialytic hypotension, Diabetic nephropathy